- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 7/02 - Recovery or purification
Patent holdings for IPC class C12N 7/02
Total number of patents in this class: 1058
10-year publication summary
|
55
|
52
|
66
|
72
|
64
|
77
|
72
|
53
|
50
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4251 |
19 |
| Bavarian Nordic A/S | 261 |
19 |
| Crucell Holland B.V. | 101 |
9 |
| Janssen Vaccines & Prevention B.V. | 334 |
9 |
| Seqirus UK Limited | 435 |
9 |
| Transgene S.A. | 128 |
9 |
| Cytiva BioProcess R&D AB | 301 |
9 |
| BIA Separations d.o.o. | 17 |
8 |
| Genzyme Corporation | 1216 |
8 |
| Takeda Vaccines, Inc. | 210 |
8 |
| Valneva Austria GmbH | 113 |
8 |
| Novartis AG | 11297 |
7 |
| The Regents of the University of California | 19479 |
7 |
| Kaneka Corporation | 4483 |
7 |
| University of Florida Research Foundation, Inc. | 3951 |
7 |
| The Children's Hospital of Philadelphia | 748 |
7 |
| MedImmune, LLC | 486 |
7 |
| Sartorius Stedim Biotech GmbH | 801 |
7 |
| uniQure IP B.V. | 119 |
7 |
| Voyager Therapeutics, Inc. | 230 |
7 |
| Other owners | 880 |